-+ 0.00%
-+ 0.00%
-+ 0.00%

Alcon says trial shows Systane Pro PF non-inferior to Miebo in dry eye symptom relief

PUBT·10/02/2026 13:04:06
Listen to the news
Alcon says trial shows Systane Pro PF non-inferior to Miebo in dry eye symptom relief
  • Alcon disclosed new randomized trial data showing Systane Pro Preservative-Free delivered dry-eye symptom relief comparable to prescription Miebo.
  • Results were presented at the American Academy of Optometry 2026 Annual Meeting.
  • Study met its primary goal, supporting an over-the-counter option that performed similarly to a prescription alternative in symptom relief.
  • Readout could strengthen Systane’s positioning with eye-care providers, particularly for patients facing insurance or cost barriers to prescriptions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alcon AG published the original content used to generate this news brief on October 02, 2026, and is solely responsible for the information contained therein.